[1]
|
Noseworthy, J.H. (1991) Progress in determining the causes and treatment of multiple sclerosis. Nature, 399, 40-47. http://dx.doi.org/10.1038/399a040
|
[2]
|
Gonsette, R.E. (2008) Neurodegeneration in multiple sclerosis: The role of oxidatvie stress and excitotoxicity. Journal of the Neurological Sciences, 274, 48-53. http://dx.doi.org/10.1016/j.jns.2008.06.029
|
[3]
|
Sayre, L.M., Perry, G. and Smith, M.A. (2008) Oxidative stress and neurotoxicity. Chemical Research in Toxicology, 21, 172-188. http://dx.doi.org/10.1021/tx700210j
|
[4]
|
Re, R., Pellegrini, N., Protteggente, A., Pannala, A., Yang, M. and Rice-Evans, C. (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biology & Medicine, 26, 1231-1237. http://dx.doi.org/10.1016/S0891-5849(98)00315-3
|
[5]
|
el-Saadani, M., Esterbauer, H., el-Sayed, M., Goher, M., Nassar, A.Y. and Jurgens, G. (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. Journal of Lipid Research, 30, 627-630.
|
[6]
|
Buss, H., Chan, T.P., Sluis, K.B., Domigan, N.M. and Winterbourn, C.C. (1997) Protein carbonyl measurement by a sensitive ELISA method. Free Radical Biology & Medicine, 23, 361-366. http://dx.doi.org/10.1016/S0891-5849(97)00104-4
|
[7]
|
Uttara, B., Singh, A.V., Zamboni, P. and Mahajan, R.T. (2009) Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology, 7, 65-74. http://dx.doi.org/10.2174/157015909787602823
|
[8]
|
Besler, H.T. and Comoglu, S. (2003) Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutritional Neuroscience, 6, 189-196. http://dx.doi.org/10.1080/1028415031000115945
|
[9]
|
Miller, E., Mrowicka, M., Saluk-Juszczak, J. and Majsterek, I. (2011) The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis. Neurochemical Research, 36, 1012-1016. http://dx.doi.org/10.1007/s11064-011-0442-1
|
[10]
|
Frei, B., Stocker, R. and Ames, B.N. (1988) Antioxidant defences and lipid peroxidation in human blood plasma. Proceedings of the National Academy of Sciences of USA, 85, 9748-9752. http://dx.doi.org/10.1073/pnas.85.24.9748
|
[11]
|
Miller, E., Walczak, A., Saluk, J., Ponczek, M.B. and Majsterek, I. (2012) Oxidative modification of patient’s plasma proteins and its role in pathogenesis of multiple sclerosis. Clinical Biochemistry, 45, 26-30. http://dx.doi.org/10.1016/j.clinbiochem.2011.09.021
|
[12]
|
Kuracka, L. (2011) Association between degradation products of purine nucleotides in cerebrospinal fluid and levels of some lipofilic vitamins in plasma of patients with multiple sclerosis. Proceedings of the 50th Faculty Conference of Student Science Work, 6th Scientific Conference of Graduants MF CU, 14 April 2011, Bratislava, 67-70.
|
[13]
|
Amorini, A.M., Petzold, A., Tavazzi, B., Eikelenboom, J., Keir, G., Belli, A., Giovannoni, G., Di Pietro, V., Polman, C., D’Urso, S., Vagnozzi, R., Uitdehaag, B. and Lazzarino, G. (2009) Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clinical Biochemistry, 42, 1001-1006. http://dx.doi.org/10.1016/j.clinbiochem.2009.03.020
|
[14]
|
Miller, E., Mrowicka, M., Malinowska, K., Mrowicki, J., Saluk-Juszczak, J. and Kedziora, J. (2009) Effects of wholebody cryotherapy on oxidative stress in multiple sclerosis patients. Journal of Thermal Biology, 35, 406-410. http://dx.doi.org/10.1016/j.jtherbio.2010.08.006
|
[15]
|
Virgili, N., Mancera, P., Wappenhans, B., Sorrosal, G., Biber, K., Pugliese, M. and Espinosa-Parrilla, J.F. (2013) KATP channel opener diazoxide prevents neurodegeneration: A new mechanism of action via antioxidative pathway activation. PLoS One, 11, 8-9.
|
[16]
|
Sadowska-Bartosz, I., Adamczyk-Sowa, M., Galiniak, S., Mucha, S., Pierzchala, K. and Bartosz, G. (2013) Oxidative modification of serum proteins in multiple sclerosis. Neurochemisty International, 63, 507-516.
|